Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) ...

We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...

In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Altimmune (ALT – Research Report). The company’s shares ...

William Blair analyst Jason Ader reiterated a Buy rating on Varonis Systems (VRNS – Research Report) today. The company’s shares opened today ...

Equities research analysts at William Blair lifted their Q1 2025 earnings estimates for HealthStream in a research note issued on Tuesday, February 25th. William Blair analyst R. Daniels now forecasts ...

Analysts at William Blair upped their FY2025 EPS estimates for Straumann in a report issued on Monday, February 24th. William Blair analyst B. Vazquez now forecasts that the company will post earnings ...

William Blair analyst Andy Hsieh initiated coverage of BioAge Labs (BIOA) with a Market Perform rating.Discover the Best Stocks and Maximize ...

In a report released today, Ryan Daniels from William Blair maintained a Hold rating on Teladoc (TDOC – Research Report). The company’s shares ...

Research analysts at William Blair increased their Q1 2025 earnings estimates for shares of Tactile Systems Technology in a note issued to investors on Monday, February 24th. William Blair analyst M.

Stock analysts at William Blair lowered their Q1 2025 EPS estimates for shares of AMN Healthcare Services in a report issued ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...

William Blair Global Leaders Fund earns a Below Average Process Pillar rating. The process benefits from low costs across its parent firm's funds, whose fees rank in their respective category's ...